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Objective. Intestinal ischemia reperfusion (II/R) injury plays a critical role in remote organ dysfunction, such as lung injury, which is
associated with nuclear factor erythroid 2-related factor 2 (Nrf2)/heme oxygenase-1 (HO-1) signaling pathway. In the present study,
we tested whether ginsenoside Rb1 attenuated II/R induced lung injury by Nrf2/HO-1 pathway.Methods. II/R injury was induced
in male C57BL/6J mice by 45min of superior mesenteric artery (SMA) occlusion followed by 2 hours of reperfusion. Ginsenoside
Rb1 was administrated prior to reperfusion with or without ATRA (all-transretinoic acid, the inhibitor of Nrf2/ARE signaling
pathway) administration before II/R. Results. II/R induced lung histological injury, which is accompanied with increased levels of
malondialdehyde (MDA), interleukin- (IL-) 6, and tumor necrosis factor- (TNF-) 𝛼 but decreased levels of superoxide dismutase
(SOD) and IL-10 in the lung tissues. Ginsenoside Rb1 reduced lung histological injury and the levels of TNF-𝛼 and MDA, as well
as wet/dry weight ratio. Interestingly, the increased Nrf2 and HO-1 expression induced by II/R in the lung tissues was promoted by
ginsenoside Rb1 treatment. All these changes could be inhibited or prevented by ATRA. Conclusion. Ginsenoside Rb1 is capable of
ameliorating II/R induced lung injuries by activating Nrf2/HO-1 pathway.
1. Introduction
Intestinal ischemia reperfusion (II/R) injury is a life-
threatening clinical surgical emergency, which is associated
with the exacerbation of intestinal injury and a systemic
inflammatory response leading to progressive distal organ
impairment, finally resulting in cardiocirculatory, respiratory,
hepatic, and renal failure. Acute respiratory distress syn-
drome (ARDS) induced by lung injury is one of the most
serious complications.These clinical problems were involved
in diverse causes such as intestinal barrier damage, bacteria
translocation and oxidative stress, and activation of multiple
inflammatory mediators [1, 2]. However, there still remain
many doubts in the pathophysiology and therapeutics of II/R
induced remote organ injury, especially lung injury.
Ginsenoside Rb1, a major active constituent of ginseng
(Panax ginseng), has antioxidative effects and has been
demonstrated to protect multiple organs from ischemia
reperfusion injury [3–9]. However, it has not been fully
elucidated whether it can also attenuate II/R induced acute
lung injury. Nuclear factor erythroid 2-related factor 2
(Nrf2)/antioxidant response element (ARE) signaling path-
way has been found as the most important endogenous
antioxidative stress mechanism. It has been reported that
Nrf2/ARE signaling pathway performs a fundamental role
in protecting the body against the xenobiotics and oxidative
injury in the pathophysiology of digestive system, circulation
system, nervous system, and immune system diseases [10–
13]. Nrf2 is a nuclear transcription factor that controls the
expression and coordinates induction of a battery of defensive
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genes encoding detoxifying enzymes and antioxidant pro-
teins [14]. In response to stimulation of oxidative stress, Nrf2
translocates from the cytoplasm into the nucleus and then
binds to a cis-acting enhancer sequence designated as ARE
and regulates AREmediated antioxidant enzyme gene such as
heme oxygenase-1 (HO-1) expression and induction [15, 16].
HO-1 belongs to a member of the heat shock protein family
and plays a significant protective role against inflammatory
processes and oxidative tissue injury [17].
In this study, we established a superior mesenteric artery
(SMA) occlusion/reperfusion mice model to induce lung
injury. We used ATRA (all-transretinoic acid) as inhibitor
of Nrf2/ARE signaling pathway, which interfered in the
recruitment ofNrf2 to theARE, thus disrupting the activation
of ARE-driven genes [18]. With the treatment of ginsenoside
Rb1, we aim to investigatewhether ginsenoside Rb1 attenuates
acute lung injury (ALI) induced by II/R inmice viaNrf2/ARE
pathway.
2. Material and Methods
2.1. Mice. The current study was approved by the Ani-
mal Care Committee of Wuhan University, China, and
was performed in accordance with National Institutes of
Health guidelines for the use of experimental animals. Male
C57BL/6mice (9–12 weeks old; 17–22 g) were purchased from
HUNAN SLAC JD Laboratory Animal Co. Ltd., China. They
were housed under standard laboratory conditions at 22–
24∘C, relative humidity of 50 ± 15%, and kept on a 12 h
day/night rhythm with free access to water and food. All
experimental protocols conducted in the mice were carried
out in accordance with the Guide for the Care and Use of
LaboratoryAnimals by theNational Institutes ofHealth (NIH
Publication number 80-23).
2.2. Surgical Preparation. Animals were anesthetized intra-
peritoneally with pentobarbital sodium (50mg/kg body
weight). Amidline laparotomywas performed; then the supe-
rior mesenteric artery (SMA) was isolated. The II/R injury
was established by occluding SMA with a microvascular
clip for 45 minutes followed by 2 hours of reperfusion as
previously described [19]. Ischemia was recognized by the
existence of pulseless or pale color of the small intestine. The
return of pulses and the reestablishment of the pink color
were assumed to indicate valid reperfusion of the intestine.
The Sham group underwent the same surgical process, apart
from occlusion of SMA. After 2 h reperfusion, the mice were
killed. A median sternotomy was performed; the lung and
intestine samples were obtained for further analysis.
2.3. Experimental Protocol. The mice were randomly allo-
cated into eight groups (𝑛 = 8 in each group) (Figure 1):
(1) Sham surgical preparation including isolation of the SMA
without occlusion was performed (Sham); (2) mice were
subjected to II/R without treatment (II/R); (3) mice were
subjected to II/R with treatment of normal saline 10 minutes
before reperfusion (II/R + NS); (4), (5) mice were treated
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Figure 1: Experimental protocols. Mice were subjected to 45min
of SMA occlusion followed by 2 h of reperfusion. II/R: intestinal
ischemia/reperfusion, NS: normal saline, Rb1: ginsenoside Rb1, and
ATRA: all-transretinoic acid.
with 30mg/kg (II/R + Rb1-30) or 60mg/kg (II/R + Rb1-
60) ginsenoside Rb1, in which surgery was performed as
in the II/R group with administration of the ginsenoside
Rb1 intraperitoneally 10 minutes before reperfusion; (6) mice
were subjected to Sham surgery and treated with ATRA
(ATRA+Sham), which is the inhibitor ofNrf2/ARE signaling
pathway; (7) mice were subjected to II/R and treated with
ATRA (ATRA + II/R); (8) mice were subjected to II/R and
treated with ATRA and 60mg/kg ginsenoside Rb1 as group
5 (ATRA + II/R + Rb1-60). During the last two weeks before
the operation, themice in the group 6, 7, 8 received ATRA i.p.
daily at 10mg/kg and fed on a vitamin A-deficient diet, and
the mice in the other groups received the equivalent volume
of corn oil and fed on a control normal diet [18].
2.4. Lung Histology. The left lung was removed and fixed in
10% formalin. Following embedding in paraffin, the sections
of 4 𝜇m were stained with hematoxylin and eosin for light
microscopy. Semiquantitative analysis of lung histopathology
was performed by scoring the tissues based on lung edema,
infiltration of inflammatory cells, alveolar hemorrhage, hya-
line membrane, and atelectasis: no lesion, 0; injured area ⩽
25%, 1; injured area 26–50%, 2; injured area 51–70%, 3; injured
area 71–90%, 4; injured area > 90%, 5. A total of three fields
were randomly selected for each slide and the average was
used as the histopathology score [20].
2.5. Histopathological Assessment of Intestines. After reperfu-
sion, 1 cm of small intestine without adipose tissue was taken
from the same place at the distal end of ileum and fixed in
4% formaldehyde. After embedding in paraffin, 4𝜇msections
were stained with hematoxylin and eosin before assessment
by light microscopy (original magnification ×200, Olympus
BX50; Olympus Optical, Tokyo, Japan).
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Figure 2: Intestinal histologic evaluation in the groups. ((a)–(h)) Histopathologic changes of the small-intestinal mucosa were observed
under light microscopy (hematoxylin and eosin, ×200). (a) Sham group, (b) II/R group, (c) II/R + NS group, (d) II/R + Rb1-30 group, (e)
II/R + Rb1-60 group, (f) ATRA + Sham group, (g) ATRA + II/R group, and (h) ATRA + II/R + Rb1-60 group. Data are mean ± SD, 𝑛 = 10;
∗
𝑃 < 0.05 versus Sham group, #𝑃 < 0.05 versus II/R group, and $𝑃 < 0.05 versus II/R + Rb1-60 group.
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Figure 3: Histopathologic changes in mice lung under light microscopy (hematoxylin and eosin, ×200). (a) Sham group, (b) II/R group, (c)
II/R + NS group, (d) II/R + Rb1-30 group, (e) II/R + Rb1-60 group, (f) ATRA + Sham group, (g) ATRA + II/R group, and (h) ATRA + II/R +
Rb1-60 group. Data are mean ± SD, 𝑛 = 10; ∗𝑃 < 0.05 versus Sham group, #𝑃 < 0.05 versus II/R group, and $𝑃 < 0.05 versus II/R + Rb1-60
group.
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Figure 4:The effects of ginsenoside Rb1 on the lung wet/dry weight
ratio. Data are mean ± SD, 𝑛 = 5; ∗𝑃 < 0.05 versus Sham group,
#
𝑃 < 0.05 versus II/R group, and $𝑃 < 0.05 versus II/R + Rb1-60
group.
Using the improved Chiu score method [21] to evaluate
intestinal mucosal damage, higher scores are interpreted to
indicatemore severe damage. Criteria of Chiu grading system
consist of 5 subdivisions according to the changes of villus
and gland of intestinal mucosa: grade 0, normal mucosa;
grade 1, development of subepithelial Gruenhagen’s space at
the tip of villus; grade 2, extension of the space withmoderate
epithelial lifting; grade 3, massive epithelial lifting with a few
denuded villi; grade 4, denuded villi with exposed capillaries;
and grade 5, disintegration of the lamina propria, ulceration,
and hemorrhage.
2.6. Assessment of Pulmonary Edema. The left lung was
harvested. After the lung wet weight was measured, the
lungs were placed in a calorstat at 60∘C for 48 h, and then
the specimen was reweighed. The pulmonary edema was
estimated by lung wet/dry weight ratio [22].
2.7. Immunohistochemical Assessment. Paraffin-embedded
lung sections were stained using the streptavidin-biotin
complex immunohistochemistry technique for HO-1 and
Nrf2 detection. Brown staining in the cytoplasm and/or
nucleus was considered an indicator of positive expression.
With the Image-Pro Plus version 6.0, results were evaluated
semiquantitatively according to optical density values of
positive expression.
2.8. Western Blot Analysis. The right lungs were removed
and nuclear fractions were prepared using a Nuclear and
Cytoplasmic Protein Extraction Kit (Beyotime Institute of
Biotechnology, China) according to the manufacturer’s pro-
tocol. Western blot analysis was carried out as described [23].
Primary antibodies (working concentration) usedwere rabbit
polyclonal antibodies against mice Nrf2 (1 : 2000, H-300,
Santa Cruz Biotechnology, CA), HO-1 (1 : 1000, H-105, Santa
CruzBiotechnology, CA), andLaminB1 (1 : 2000,H-90, Santa
Cruz Biotechnology, CA). The HRP-conjugated secondary
antibody was goat anti-rabbit IgG (Beyotime Institute of
Biotechnology, China) used at 1 : 2000. Lamin B was used
as an internal control. The ECL Western blotting detection
reagents (Beyotime Institute of Biotechnology, China) were
used for visualization of the protein bands. The intensities of
the bandswere analyzedwith quantity one software (Bio-Rad,
Hercules, CA).
2.9. Determination of Tissue Tumor Necrosis Factor Alpha
(TNF-𝛼), Interlukin-6 (IL-10), and Interlukin-6 (IL-6). Tissue
levels of TNF-𝛼, IL-10, and IL-6 were determined using
commercially available ELISA kits (R&D, Minneapolis, MN)
according to manufacturer’s instructions. The results were
expressed as pg/mL.
2.10. Determination of Tissue MDA Level and SOD Activity.
The right lung tissues were homogenized on ice in normal
saline. The homogenates were centrifuged at 4000 g⋅min−1
at 4∘C for 10min. The MDA level in the supernatants
was determined by the measurement of thiobarbituric acid-
reactive substances levels (assay kits were supplied byNanjing
Jiancheng Corp., China) as previously described [24]. The
results were calculated as nmol⋅100mg−1 protein. The SOD
activity in the supernatants was evaluated by inhibition of
nitroblue tetrazolium (NBT) reduction by O2− generated
by the xanthine/xanthine oxidase system (assay kits were
supplied by Nanjing Jiancheng Corp., China) in accordance
with the previous method [24].The results were expressed by
U⋅100mg−1 protein.
2.11. Statistical Analysis. Data are presented as mean ± SD.
Statistical comparison amongmultiple groupswas performed
by one-way analysis of variance (ANOVA) followed by
Newman-Keulsmultiple comparison test using theGraphPad
Prism 5.0 software (GraphPad Software Inc., San Diego, CA,
USA). A value of 𝑃 < 0.05 was considered statistically
significant.
3. Results
3.1. Histopathological Assessment of Intestines. The II/R group
showed edema in the villi, inflammatory cells infiltration, and
damaged areas interspersed with hemorrhage. In addition,
the gap between epithelial cells significantly increased and
capillaries and lymph vessels were markedly dilated. Normal
villi were seen in the intestine of the Sham group andATRA+
Sham group under the light microscope. Ginsenoside Rb1 at
the dose of 30mg/kg and 60mg/kg both significantly atten-
uated the histological intestine injury (Figure 2). However,
there is little amelioration of the intestine injury induced by
II/R in the ATRA + II/R + Rb1-60 group.
3.2. Pathologic Alternations of Lung Tissue. The lungs from
II/R group showed damaged areas interspersed with hemor-
rhage, inflammatory cell infiltration, and pulmonary edema,
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Figure 5: The changes of lung tissue SOD activity and MDA levels. Data are mean ± SD, 𝑛 = 10; ∗𝑃 < 0.05 versus Sham group, #𝑃 < 0.05
versus II/R group, and $𝑃 < 0.05 versus II/R + Rb1-60 group.
while little damage was seen in the lungs of the sham
group and ATRA + Sham group under the light micro-
scope. Ginsenoside Rb1 at the both doses of 30mg/kg and
60mg/kg significantly attenuated the histological lung injury
(Figure 3). However, there is little amelioration of the lung
injury induced by II/R in the ATRA + II/R + Rb1-60 group.
This indicates that ATRA attenuated the protective action
of ginsenoside Rb1 against II/R induced lung damage in the
mice.
3.3. Changes of LungWet/DryWeight Ratio. Wenext assessed
the lung wet/dry weight ratio as indicators of lung permeabil-
ity damage. As shown in Figure 4, the lung wet/dry weight
ratio was significantly higher in the II/R group than the Sham
group (𝑃 < 0.05). Compared with the II/R group, the lung
wet/dry ratio was decreased significantly after the treatment
of ginsenoside Rb1 (𝑃 < 0.05, II/R + Rb1-30 or II/R + Rb1-60
versus II/R). This decrease was reversed by administration of
ATRA (𝑃 > 0.05, ATRA + II/R + Rb1-60 versus II/R). There
was no significant difference between the Sham and ATRA +
Sham group or II/R and II/R + NS group (𝑃 > 0.05).
3.4. Changes of the Level of MDA and the Activity of SOD.
Oxidative stress has been proposed as an important mech-
anism of the development of II/R induced organ damage.
Reperfusion or reoxygenation will activate recovery of aero-
bic metabolism and results in an overload of reactive oxygen
species (ROS). Robust ROS generation generates excessive
hydroxyl radicals, which are very unstable and have a high
potential to damage cellular structures, enzymes, or channel
proteins on the cellular membrane. We examined the effects
of ginsenosideRb1 on lung tissue lipidic peroxidation product
(MDA) levels and the antioxidative SOD activity. As shown in
Figure 5, treatment with 30mg/kg and 60mg/kg ginsenoside
Rb1 significantly reduced MDA levels and increased SOD
activity, and this effect was inhibited by administration of
ATRA.
3.5. Changes of Tissue TNF-𝛼, IL-10, and IL-6 Levels. In
a number of clinical studies, microinflammation has been
found to be associated with processes that may be related to
II/R caused injury. As shown in Figure 6, the level of tissues
TNF-𝛼 and IL-6 in the II/R group was significantly higher
than that in the Sham group.However, the level of tissue IL-10
was significantly reduced in the II/R group compared to that
in the Sham group. Treatment with 30mg/kg and 60mg/kg
ginsenoside Rb1 significantly reduced TNF-𝛼 and IL-6 levels
and increased IL-10 levels. After treatment with ATRA, this
effect was inhibited.
3.6. Effects of Ginsenoside Rb1 on HO-1 and Nrf2 Expression
in Lung Tissue by Immunohistochemical Detection. The lung
tissue was obtained to measure the expression of Nrf2 and
HO-1 by immunohistochemical assay. In the II/R group,
both cytoplasm and nuclei of the lung tissue showed Nrf2
expression, but the expression of HO-1 was showed in the
cytoplasm. Compared with the Sham group, the expression
of Nrf2 and HO-1 in the II/R group increased significantly.
After treatment with ginsenoside Rb1 at dose 30 or 60mg/kg,
the expression ofNrf2 andHO-1wasmuchhigher than that in
the II/R group. In theATRA+ II/R andATRA+ II/R+Rb1-60
groups, Nrf2 was also expressed obviously in the cytoplasm
and nuclei, though mild expression of HO-1 could be seen in
the cytoplasm of lung tissue in these groups (Figures 7 and 8).
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Figure 6: Cytokine levels in lung from mice. Cytokine levels were determined in lung homogenate using multiplex analysis: (a) TNF-𝛼, (b)
IL-6, and (c) IL-10. Data are mean ± SD, 𝑛 = 10; ∗𝑃 < 0.05 versus Sham group, #𝑃 < 0.05 versus II/R group, and $𝑃 < 0.05 versus II/R +
Rb1-60 group.
3.7. Effects of Ginsenoside Rb1 on Cytoplasmic HO-1 and
Nuclear Nrf2 Expression in Lung Tissue by Western Blot-
ting Analysis. To further confirm the protective effect of
ginsenoside Rb1 on the lung tissue against II/R injury,
protein expression of nuclear Nrf2 and cytoplasmic HO-1
was examined by Western blot. As shown in Figure 9, Nrf2
and HO-1 expression were both increased markedly in the
II/R group as compared with the Sham group. II/R with Rb1
intervention further increased the expression of Nrf2 and
HO-1 significantly. ATRA administration has no effects on
the cytoplasmic HO-1 expression as compared with the Sham
group. This indicated that Rb1 induced cytoplasmic HO-1
expression was inhibited by ATRA. There was no significant
difference inNrf2 expression between theATRA+ II/R group
and the II/R group or between the ATRA + II/R + Rb1-60
group and the II/R group.
4. Discussion
In this study, we have demonstrated in a mice model that
45min occlusion of SMA followed by 2 h of reperfusion
caused significant lung injury as evidenced by pathologic
morphologic changes seen in the lung tissue, as well as the
increased lung wet/dry ratio, which is in accordance with the
previous reports [25]. We found that postischemia treatment
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Figure 7: Expression of Nrf2 in the lung tissue under the light microscope (streptavidin-biotin complex immunohistochemistry, ×200). (a)
Sham group, (b) II/R group, (c) II/R + NS group, (d) II/R + Rb1-30 group, (e) II/R + Rb1-60 group, (f) ATRA + Sham group, (g) ATRA + II/R
group, and (h) ATRA + II/R + Rb1-60 group. Data are mean ± SD, 𝑛 = 5; ∗𝑃 < 0.05 versus Sham group, #𝑃 < 0.05 versus II/R group, and
$
𝑃 < 0.05 versus II/R + Rb1-60 group.
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Figure 8: Expression of HO-1 in the lung tissue under the light microscope (streptavidin-biotin complex immunohistochemistry, ×200). (a)
Sham group, (b) II/R group, (c) II/R + NS group, (d) II/R + Rb1-30 group, (e) II/R + Rb1-60 group, (F) ATRA + Sham group, (g) ATRA + II/R
group, and (h) ATRA + II/R + Rb1-60 group. Data are mean ± SD, 𝑛 = 5; ∗𝑃 < 0.05 versus Sham group, #𝑃 < 0.05 versus II/R group, and
$
𝑃 < 0.05 versus II/R + Rb1-60 group.
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Figure 9:Western blotting analysis of the presence of Nrf2 in nuclear proteins andHO-1 in cytoplasmic proteins in themice lung tissue. Data
obtained from quantitative densitometry were presented as mean ± SD. 𝑛 = 10, ∗𝑃 < 0.05 versus Sham group, #𝑃 < 0.05 versus II/R group,
and $𝑃 < 0.05 versus II/R + Rb1-60 group.
with ginsenoside Rb1 enhanced Nrf2 translocation to the
nucleus in the lung tissues of mice and Rb1 treatment could
reduce pulmonary morphologic damage, alleviate injuries
induced by oxidative stress, and modulate inflammatory
reactions. Further, Nrf2 function inhibition with ATRA
reverted the pulmonary protective effects of ginsenoside
Rb1, indicating that ginsenoside Rb1 confers its respiratory
protection via Nrf2/ARE signaling in the II/R induced acute
lung injury.
The mechanisms of acute lung injury induced by II/R are
complex. It is thought that the damage of intestinal mucosal
barrier following II/R causes the dislocation of bacteria or
endogenous endotoxin, thus leading to increased oxidative
stress and systemic inflammatory reaction, which is one of
the main reasons for acute lung injury.
Ginseng is one of the most widely used herbal medicines.
Ginsenosides, the major active ingredient of ginseng, have
been noticed for their multiple pharmacological effects on
antioxidation, signal transduction pathways, and interaction
with receptors [26]. Oxidative stress refers to themismatched
redox equilibrium between the production of free radicals
and the ability of cells to defend against them. One feasible
way to prevent free radical mediated cellular injuries is to
augment the oxidative defense capacity through intake of
antioxidants. Moreover, the induction of endogenous phase
II detoxifying enzymes or antioxidative proteins seems to
be a reasonable strategy for delaying disease progression.
Activation of Nrf2/ARE plays an important role in protecting
cells from oxidative stress [27, 28]. The ability of Nrf2 to
upregulate the expression of antioxidant genes via ARE
suggests that increasing Nrf2 activity may provide a useful
system for combating oxidative insults. Several recent reports
have demonstrated that coordinate upregulation of ARE-
driven genes protects organs from ischemia reperfusion
injury [29–31]. Accumulating evidence also suggests that
upregulation of HO-1 expression and the subsequent increase
in HO activity may confer an adaptive survival response
against oxidative insults. Our previous studies showed that
Rb1 reduces renal apoptosis and alleviates renal dysfunction
after II/R in part through the Nrf2/ARE pathway [32]. Wang
et al. demonstrated that Rb1 attenuates lung injury induced
by II/R via inhibiting NF-𝜅B activation [33]. To determine
the mechanism by which postischemia treatment with Rb1
reduces II/R-induced ROS generation, we examined the
effect of ginsenoside Rb1 on Nrf2 and HO-1 expression in
mice lung tissues. Our present study demonstrated that Rb1
increased nuclearNrf2 protein and cytoplasmicHO-1 protein
expressions in lung tissues of mice after II/R. The increase of
HO-1 expression byRb1 conferred cytoprotection against II/R
induced oxidative stress. In addition, previous studies have
shown that ATRA does not affect the half-life of Nrf2 or its
nuclear translocation. ATRA inhibits Nrf2 function by stim-
ulating the formation of Nrf2:RAR𝛼-containing complexes
that do not bind to the ARE [18]. We showed that ATRA, as a
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potent inhibitor for combination of Nrf2 with ARE, partially
reversed the protective effects of Rb1, thus providing further
evidence for Nrf2/ARE as a possible cytoprotective pathway
for Rb1.
Ginseng extract was reported to have immunomodu-
latory effects [34]. Smolinski and Pestka [35] reported that
immunologic effects include modulation of lipopolysac-
charide-induced proinflammatory cytokine production in
vitro and in vivo by ginsenoside Rb1.This was also confirmed
with our study in which Rb1 significantly reduced the tissue
level of TNF-𝛼, IL-6, and IL-10. These results show that Rb1
may have multiple mechanisms of action that affect cytopro-
tection by both reducing ROS generation and increasing the
anti-inflammatory effect.
In summary, our present study indicates that ginsenoside
Rb1 alleviates acute lung injury following II/R via activating
Nrf2/ARE pathway.The experiment data may help us further
understand the pharmacological effects of Rb1 and also
suggest a new therapeutic target to protect the body from
II/R injury. However, further studies need to be performed in
transfection of lung endothelial cells and intestinal epithelial
cells with the siRNA and expressing plasmid for Nrf2 to
confirm the findings of the current study.
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